Fate Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Fate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fate Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fate Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $64k | 50k | 1.26 |
| 2025-03-31 | $2.7M | 3.4M | 0.79 |
| 2024-12-31 | $2.8M | 1.7M | 1.65 |
| 2024-09-30 | $6.4M | 1.8M | 3.50 |
| 2024-06-30 | $5.1M | 1.6M | 3.28 |
| 2024-03-31 | $13M | 1.8M | 7.34 |
| 2023-12-31 | $7.8M | 2.1M | 3.74 |
| 2023-09-30 | $5.5M | 2.6M | 2.12 |
| 2023-06-30 | $13M | 2.7M | 4.76 |
| 2023-03-31 | $17M | 1.6M | 10.41 |
| 2022-12-31 | $23M | 1.5M | 15.63 |
| 2022-06-30 | $48M | 2.0M | 24.10 |
| 2022-03-31 | $72M | 1.9M | 38.77 |
| 2021-12-31 | $109M | 1.9M | 56.12 |
| 2021-03-31 | $56M | 698k | 80.88 |
| 2020-12-31 | $55M | 600k | 92.26 |
| 2020-09-30 | $23M | 594k | 39.39 |
| 2020-06-30 | $18M | 528k | 34.31 |
| 2020-03-31 | $10M | 464k | 22.21 |
| 2019-12-31 | $6.4M | 327k | 19.56 |
| 2019-09-30 | $4.3M | 280k | 15.53 |
| 2019-06-30 | $5.6M | 274k | 20.44 |
| 2019-03-31 | $4.7M | 268k | 17.57 |
| 2018-12-31 | $5.9M | 460k | 12.83 |
| 2018-09-30 | $7.2M | 442k | 16.29 |
| 2018-06-30 | $5.1M | 451k | 11.35 |
| 2018-03-31 | $4.2M | 427k | 9.76 |
| 2017-12-31 | $177k | 29k | 6.08 |
| 2017-06-30 | $68k | 21k | 3.25 |
| 2017-03-31 | $11k | 2.2k | 5.00 |
| 2016-09-30 | $15k | 4.9k | 3.04 |